<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Badjatia N</submitter><funding>NIA NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>RRD VA</funding><funding>NINDS NIH HHS</funding><pagination>46-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8093316</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Aneurysmal subarachnoid hemorrhage (SAH) survivors live with long-term residual physical and cognitive disability. We studied whether neuromuscular electrical stimulation (NMES) and high-protein supplementation (HPRO) in the first 2 weeks after SAH could preserve neuromotor and cognitive function as compared to standard of care (SOC) for nutrition and mobilization.&lt;h4>Methods&lt;/h4>SAH subjects with a Hunt Hess (HH) grade > 1,modified Fisher score > 1 and BMI &lt; 40 kg/m&lt;sup>2&lt;/sup> were randomly assigned to SOC or NMES + HPRO. NMES was delivered to bilateral quadricep muscles daily during two 30-min sessions along with HPRO (goal:1.8 g/kg/day) between post-bleed day (PBD) 0 and 14. Primary endpoint was atrophy in the quadricep muscle as measured by the percentage differen</pubmed_abstract><journal>Neurocritical care</journal><pubmed_title>Neuromuscular Electrical Stimulation and High-Protein Supplementation After Subarachnoid Hemorrhage: A Single-Center Phase 2 Randomized Clinical Trial.</pubmed_title><pmcid>PMC8093316</pmcid><funding_grant_id>I01 RX000550</funding_grant_id><funding_grant_id>P30 DK072488</funding_grant_id><funding_grant_id>R01 NS105503</funding_grant_id><funding_grant_id>IK6 RX003977</funding_grant_id><funding_grant_id>P30 AG028747</funding_grant_id><pubmed_authors>Sanchez S</pubmed_authors><pubmed_authors>Simard JM</pubmed_authors><pubmed_authors>Motta M</pubmed_authors><pubmed_authors>Chang W</pubmed_authors><pubmed_authors>Parikh G</pubmed_authors><pubmed_authors>Wittenberg GF</pubmed_authors><pubmed_authors>Judd G</pubmed_authors><pubmed_authors>Morris N</pubmed_authors><pubmed_authors>Sorkin J</pubmed_authors><pubmed_authors>Hausladen R</pubmed_authors><pubmed_authors>Hering D</pubmed_authors><pubmed_authors>Ryan AS</pubmed_authors><pubmed_authors>Badjatia N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuromuscular Electrical Stimulation and High-Protein Supplementation After Subarachnoid Hemorrhage: A Single-Center Phase 2 Randomized Clinical Trial.</name><description>&lt;h4>Introduction&lt;/h4>Aneurysmal subarachnoid hemorrhage (SAH) survivors live with long-term residual physical and cognitive disability. We studied whether neuromuscular electrical stimulation (NMES) and high-protein supplementation (HPRO) in the first 2 weeks after SAH could preserve neuromotor and cognitive function as compared to standard of care (SOC) for nutrition and mobilization.&lt;h4>Methods&lt;/h4>SAH subjects with a Hunt Hess (HH) grade > 1,modified Fisher score > 1 and BMI &lt; 40 kg/m&lt;sup>2&lt;/sup> were randomly assigned to SOC or NMES + HPRO. NMES was delivered to bilateral quadricep muscles daily during two 30-min sessions along with HPRO (goal:1.8 g/kg/day) between post-bleed day (PBD) 0 and 14. Primary endpoint was atrophy in the quadricep muscle as measured by the percentage differen</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-08T02:01:30.709Z</modification><creation>2025-04-04T08:13:40.877Z</creation></dates><accession>S-EPMC8093316</accession><cross_references><pubmed>33150572</pubmed><doi>10.1007/s12028-020-01138-4</doi></cross_references></HashMap>